Pharmaceuticals & Biotechnology


How Swanson Health Products Implemented AI-Powered Pricing Technology

#artificialintelligence

Swanson Health Products and its 50-year-old private label supplement brand worked with Feedvisor to implement dynamic pricing into its business model. For the past six months, Swanson Health Products has been using Feedvisor's AI-powered pricing technology to help boost sales and profitability. As a result, Swanson's ecommerce revenue is up 60% year-over-year and total sales through Amazon are up 35%. In this latest edition of the MCM CommerceChat podcast, Patrick Yatskis, Senior Digital Marketing Manager of Swanson's Health Products and Victor Rosenman, CEO of Feedvisor discuss how it helped the brand stand out among the competition.


A List of Artificial Intelligence Tools for Industry Specific

#artificialintelligence

Here's a look at industry specific companies that utilise various forms of artificial intelligence to solve some really interesting and particular problems for different markets. If you want to be included in any of the list don't forget to comment below. If you use Apple News or similar simple visit the site on a web browser to make comments. Imagia -- helps detect changes in cancer early Kuznech -- computer vision products range Lunit Inc. -- a range of medical imaging software Zebra Medical Vision -- medical imaging to help physicians and practitioners Aerial Achron -- automated UAV operations Airware -- drones for industrial purposes Alive.ai Developers, Studios and Consultants (only a few listed) Aitia Amplify Applied AI Blindspot Solutions Cogent Crossing Minds DSP Expert Systems Explosion Minds.ai


From Microbiology to Machine Learning with Springboard

#artificialintelligence

Microbiology and MBA grad JK started to learn about big data and machine learning in his job, but wanted to learn more about data science in a structured environment. He enrolled in Springboard's Machine Learning Career Track to learn about ML and AI online. JK tells us how he balanced his full-time job with the Springboard bootcamp (hint: he didn't sleep much), and how networking at conferences helped him land his new job as a Data Engineer at KPMG! What is your educational and career background? I didn't come from a computer science (CS) background. My undergrad was in microbiology, immunology and molecular genetics. I then completed an MBA with a concentration in Accounting and Finance, working at the Australian Chamber of Commerce in Korea. And that's where I got a taste of some CS database work.


Vital: The Future of Healthcare

#artificialintelligence

Vital: The Future of Healthcare is an anthology of short stories. Vital has already gathered stories from leading futurist writers, weaving together disparate visions of what comes next in health and health science. Our visions of the future -- whether dark or hopeful, thrilling or mundane -- have always challenged us to examine our world. What challenges will we face? Vital: The Future of Healthcare aims to explore these questions as they relate to humanity's physical and mental well-being.


Using artificial intelligence in biopharma

#artificialintelligence

Drug discovery is the process of identifying new medicines for treating or curing human diseases.1 Historically, the discovery of new medicines involved extracting ingredients from natural products and basic research to find potential treatments. Progress was generally slow, frustrating and labour-intensive. The majority of drugs discovered during the 20th century were chemically synthesised small molecules, which still make up 90 per cent of drugs on the market today.2 Their advantages include simple manufacturing and administration routes. They also have low specificity and a stable shelf life, meaning they are safe and effective for large groups of people.


Quertle: Simplifying Biomedical Literature Discovery Using AI-powered Text Analytics Analytics Insight

#artificialintelligence

Quertle is an artificial intelligence company focused on text discovery and understanding in the biomedical and life sciences fields. Published information is the foundation for the entire healthcare industry – from basic research to drug discovery to clinical trials to healthcare delivery and everything in between including business aspects. Quertle's flagship product Qinsight enables unparalleled discovery of literature through AI-powered searching, integration, organization, and presentation including predictive visual analytics. Qinsight, which covers journal articles, patents, clinical trials, treatment protocols and much more, is in use by pharmaceutical and biotechnology companies, universities, research centers, and healthcare providers around the world. Quertle was founded by Jeffrey Saffer and Vicki Burnett – Ph.D. biomedical scientists who were frustrated with the inefficiencies in discovering critical publications and the waste caused by missing information.


Quertle: Simplifying Biomedical Literature Discovery Using AI-powered Text Analytics Analytics Insight

#artificialintelligence

Quertle is an artificial intelligence company focused on text discovery and understanding in the biomedical and life sciences fields. Published information is the foundation for the entire healthcare industry – from basic research to drug discovery to clinical trials to healthcare delivery and everything in between including business aspects. Quertle's flagship product Qinsight enables unparalleled discovery of literature through AI-powered searching, integration, organization, and presentation including predictive visual analytics. Qinsight, which covers journal articles, patents, clinical trials, treatment protocols and much more, is in use by pharmaceutical and biotechnology companies, universities, research centers, and healthcare providers around the world. Quertle was founded by Jeffrey Saffer and Vicki Burnett – Ph.D. biomedical scientists who were frustrated with the inefficiencies in discovering critical publications and the waste caused by missing information.


NEC and VAXIMM partner to develop personalized vaccines for cancer

#artificialintelligence

NEC Corporation, a leading firm in network technologies and IT, and VAXIMM AG, a biotech firm focused on the development of oral T-cell immunotherapies, recently announced that both the companies inked a strategic agreement for a clinical trial partnership and an equity investment for the development of innovative personalized neoantigen vaccines for cancer. The terms of this non-exclusive partnership agreement, NEC will be providing funding for the Phase I clinical trial. VAXIMM and NEC will be co-developing personalized vaccines for cancer by using the advanced artificial intelligence (AI) technology of NEC which is used in both of its Neoantigen prediction System and propriety T-cell immunotherapy technology of VAXIMM. Sources informed that the vaccines will be evaluated for several solid tumors in Phase 1 clinical trial. VAXIMM is given the responsibility to conduct the clinical trial that is anticipated to start in 2020.



Huge Untapped Potential of Artificial Intelligence in Healthcare

#artificialintelligence

A lot has been spoken about the potential of machine learning (ML) and artificial intelligence (AI) to disrupt industries. AI is already seeing a wide application in industries such as finance, education, robotics, transportation, security, and to an extent in healthcare. Today in healthcare, ML and AI application have been seen mostly in diagnostics, research and new drug development. Popular use cases being image recognition of retinal scans to detect early signs of retinopathy and disease progression in diabetics and hypertensive patients. It also serves as an aid to recognize abnormalities in ECG tests, X-rays, ultrasound, CT and MRI scans.